Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
Journal of Medical Sciences
  Year: 2013 | Volume: 13 | Issue: 5 | Page No.: 353-359
DOI: 10.3923/jms.2013.353.359
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Peripheral Blood Lymphocytes' DNA Damage in Different Treatment Outcomes of Chronic Viral C Hepatitis Genotype 4 Infection

Mohammed Mahmoud, Safinaz El-Tokhy, Dalia El-Lebedy, Mohammed Abu Elfotouh and Ghada H. El-Arabi

Abstract:
DNA fragmentation in peripheral blood lymphocytes is a reliable marker for oxidative stress occurring in the liver of chronic hepatitis C (CHC) patients which reflects a direct genotoxic effect of the virus and suggests a same genotoxic effect that might operate in the liver. Previous studies have investigated DNA damage in peripheral leukocytes of CHC patients, but none focused on genotype 4. This work aimed at examining DNA damage in different treatment outcomes of genotype 4 infection. The study included 80 viral hepatitis C genotype 4 patients and 80 healthy volunteers. HCV-RNA was detected by real-time PCR, genotype was defined by INNO-LiPA and DNA damage was assayed using alkaline Comet assay. The mean percentage of DNA damage was significantly higher in patients' group than in control group (p<0.01) and in null response (48.75±11.12) and breakthrough response (49.33±1.03) patients than in SVR patients (22.78±13.95) (p<0.05/3). Comet results revealed that all breakthrough and null response patients have DNA damage. Interestingly, 78.5% of SVR patients had DNA damage (64.3% showed mild damage and 14.2% showed marked damage). In conclusion, in genotype 4; despite clearance of serum HCV-RNA and apparent clinical resolution; SVR patients might not experience infection clearance and should be followed up being at suspected risk for virus reactivation.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

Mohammed Mahmoud, Safinaz El-Tokhy, Dalia El-Lebedy, Mohammed Abu Elfotouh and Ghada H. El-Arabi, 2013. Peripheral Blood Lymphocytes' DNA Damage in Different Treatment Outcomes of Chronic Viral C Hepatitis Genotype 4 Infection. Journal of Medical Sciences, 13: 353-359.

DOI: 10.3923/jms.2013.353.359

URL: https://scialert.net/abstract/?doi=jms.2013.353.359

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 

Curve Bottom